• Quality System
    Lixin Honor:

    Lixin Pharmaceutical was approved by U.S. Food and Drug Administration (FDA) in 2010, and had a review with zero defect in 2015.

    Lixin Pharmaceutical was approved by European Directorate for the Quality of Medicines (EDQM), European Medicines Agency (EMA) in Oct, 2016.

    A number of products receive certificates of GMP by China Food and Drug Administration (NMPA)

    About Us
    Since established in 2000, Suzhou Lixin Pharmaceutical CO., Ltd. has been aimed at develop the global normative dominant market of APIs and advanced intermediates, driven by technological innovation, taken the path of sustainable development, and gradually form a raw materials products system including anti-tumor, cardiovascular, anti-platelet and treatment of senile dementia and other areas. Lixin Pharmaceutical has already been the high-quality supplier of many global pharmaceutical companies, and also established long-term relationship with a number of well-known domestic and foreign pharmaceutical companies to achieve win-win cooperation.
    NEWS    LiXin News




    蘇州立新制藥有限公司抗腫瘤及心血管原料藥技改項目 自查評估報告公示

    蘇州立新制藥有限公司抗腫瘤及心血管原料藥技改項目 自查評估報告…...




    亚洲色欲久久久久综合网_毛片 无码 国产 午夜视频_久久久久精品免费毛片_男女18禁一区二区三区囗H毛片